Lab test aims to match advanced cancer patients with their best drug
NCT ID NCT07468422
Summary
This study is testing a new lab method called OPTin to see if it can help doctors choose the most effective existing drugs for patients with advanced solid tumors who have no standard treatments left. Researchers will take a small piece of a patient's tumor, test different drugs on it in the lab, and then use those results to guide treatment. The goal is to see if this personalized approach leads to better tumor control and remission rates.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER (ADVANCED STAGE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
China medical university hospital
Taichung, 40401, Taiwan
Conditions
Explore the condition pages connected to this study.